云南白药：第一季度实现营业收入108.41亿元，同比增长0.62%；归属于上市公司股东的净利润19.35亿元，同比增长13.67%。

Group 1 - The company achieved operating revenue of 10.841 billion yuan in the first quarter, representing a year-on-year growth of 0.62% [1] - The net profit attributable to shareholders of the listed company was 1.935 billion yuan, showing a year-on-year increase of 13.67% [1]